CME Group Goodwill decreased by 0.1% to $10.51B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $10.50B to $10.51B. Over 5 years (FY 2020 to FY 2025), Goodwill shows relatively stable performance with a -0.5% CAGR.
A significant increase indicates recent M&A activity, while a sudden decrease typically signals an impairment charge due to underperforming acquisitions.
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Standard metric for companies that grow through acquisition; comparable across all industries.
goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.54B | $10.53B | $10.53B | $10.52B | $10.48B | $10.45B | $10.48B | $10.49B | $10.49B | $10.48B | $10.50B | $10.49B | $10.49B | $10.51B | $10.49B | $10.50B | $10.52B | $10.51B | $10.51B | $10.51B |
| QoQ Change | — | -0.1% | -0.0% | -0.1% | -0.3% | -0.4% | +0.3% | +0.1% | +0.0% | -0.1% | +0.2% | -0.1% | -0.0% | +0.2% | -0.3% | +0.1% | +0.2% | -0.1% | +0.0% | -0.1% |
| YoY Change | — | — | — | — | -0.6% | -0.8% | -0.4% | -0.2% | +0.1% | +0.3% | +0.1% | -0.0% | -0.0% | +0.3% | -0.1% | +0.1% | +0.3% | +0.0% | +0.3% | +0.1% |
| Segment | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|
| CME Group Inc. | $10.52B | $10.48B | $10.45B | $10.48B | $10.49B | $10.49B | $10.48B | $10.50B |
| CBOT | $5.07B | $5.07B | $5.07B | $5.07B | $5.07B | $5.07B | $5.07B | $5.07B |
| NEX | $2.95B | $2.92B | $2.88B | $2.91B | $2.92B | $2.93B | $2.91B | $2.93B |
| Nymex | — | — | — | $2.46B | — | — | — | $2.46B |
| Other CME Segments | $40.40M | $40.40M | $40.40M | $40.40M | $40.40M | $35.80M | $35.20M | $35.90M |
| Total | $10.52B | $10.48B | $10.45B | $10.48B | $10.49B | $10.49B | $10.48B | $10.50B |
CBOT, CME Group Inc., NEX, Nymex, Other CME Segments were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.